We are live on
!
Find out more
Ensign Peak Advisors Portfolio holdings
AUM
$60.8B
1-Year Est. Return
42.06%
This Fund
S&P 500
This Quarter
Est. Return
+25.48%
1 Year Est. Return
+42.06%
3 Year Est. Return
+131.09%
5 Year Est. Return
+176.11%
10 Year Est. Return
–
AUM
$60.8B
AUM Growth
+$7.15B
(+13%)
Cap. Flow
-$361M
Cap. Flow
% of AUM
-0.59%
Top 10 Holdings %
Top 10 Hldgs %
35.18%
Holding
1,761
New
53
Increased
521
Reduced
753
Closed
37
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$294M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$211M |
| 3 |
Citigroup
C
|
+$134M |
| 4 |
Lam Research
LRCX
|
+$93.2M |
| 5 |
Merck
MRK
|
+$88M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$228M |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$185M |
| 3 |
Knight Transportation
KNX
|
+$177M |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$144M |
| 5 |
LyondellBasell Industries
LYB
|
+$105M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 36.4% |
| 2 | Financials | 11.52% |
| 3 | Healthcare | 11.15% |
| 4 | Communication Services | 9.3% |
| 5 | Consumer Discretionary | 8.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
VMRK
576
Vivmark Residential
VMRK
$50.6B
| $4.68M | 0.01% |
68,918
+13,268
| +24% | +$859K |
|
577
Tyra Biosciences
TYRA
$1.71B
| $4.68M | 0.01% |
146,537
+72,473
| +98% | +$2.4M |
|
578
Quest Diagnostics
DGX
$26.2B
| $4.66M | 0.01% |
21,990
+4,593
| +26% | +$901K |
|
579
Carlisle Companies
CSL
$14B
| $4.62M | 0.01% |
12,742
+1,847
| +17% | +$647K |
|
580
Celestica
CLS
$39.4B
| $4.61M | 0.01% |
12,648
+3,348
| +36% | +$1.26M |
|
581
Pultegroup
PHM
$23.7B
| $4.6M | 0.01% |
33,560
+5,607
| +20% | +$681K |
|
582
W.R. Berkley
WRB
$25.7B
| $4.59M | 0.01% |
65,049
-34,077
| -34% | -$2.28M |
|
583
SAB Biotherapeutics
SABS
$338M
| $4.57M | 0.01% |
1,172,641
-202,969
| -15% | -$755K |
|
584
Annexon
ANNX
$923M
| $4.57M | 0.01% |
800,516
+175,419
| +28% | +$970K |
|
|
AMRZ
585
Amrize Ltd
AMRZ
$24B
| $4.53M | 0.01% |
85,047
-70,745
| -45% | -$3.83M |
|
586
Encompass Health
EHC
$12B
| $4.48M | 0.01% |
44,313
+41
| +0.1% | +$4.25K |
|
587
Affirm
AFRM
$24.4B
| $4.45M | 0.01% |
54,549
+4,280
| +9% | +$280K |
|
588
Axsome Therapeutics
AXSM
$10.8B
| $4.43M | 0.01% |
18,091
+14,876
| +463% | +$3.23M |
|
589
Vera Therapeutics
VERA
$2.59B
| $4.4M | 0.01% |
102,598
-16,077
| -14% | -$599K |
|
590
Trade Desk
TTD
$6.78B
| $4.4M | 0.01% |
243,349
+72,307
| +42% | +$1.54M |
|
591
SLR Investment Corp
SLRC
$686M
| $4.38M | 0.01% |
354,452
-95,548
| -21% | -$1.33M |
|
592
Assurant
AIZ
$14.1B
| $4.35M | 0.01% |
16,193
-7,093
| -30% | -$1.73M |
|
593
Hyatt Hotels
H
$15.6B
| $4.35M | 0.01% |
22,431
-100
| -0.4% | -$17.5K |
|
594
Lennox International
LII
$13.5B
| $4.35M | 0.01% |
7,588
+314
| +4% | +$160K |
|
595
Regions Financial
RF
$25.9B
| $4.31M | 0.01% |
142,731
-88,206
| -38% | -$2.48M |
|
596
Corpay
CPAY
$27.3B
| $4.27M | 0.01% |
12,804
+2,400
| +23% | +$797K |
|
597
Generac Holdings
GNRC
$11.1B
| $4.26M | 0.01% |
14,561
+1,850
| +15% | +$463K |
|
598
Jazz Pharmaceuticals
JAZZ
$16B
| $4.26M | 0.01% |
17,679
+3,613
| +26% | +$792K |
|
|
COAG
599
Hemab Therapeutics
COAG
$2.07B
| $4.24M | 0.01% |
+115,394
| New | +$3.18M |
|
600
Packaging Corp of America
PKG
$21.1B
| $4.24M | 0.01% |
17,774
+590
| +3% | +$129K |
|
Similar funds
Ensign Peak Advisors's Q2 2026 Portfolio in Review
As of Q2 2026, Ensign Peak Advisors held 1,761 positions worth $60.8B, up 13% from $53.7B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Ensign Peak Advisors's Q2 2026 filing shows 53 new, 521 increased, 753 reduced and 37 closed positions. Its largest new stake was Honeywell Aerospace: 319,358 shares worth $70.6M. The largest sale was NVIDIA, an estimated $228M.
By sector, the portfolio is most concentrated in Technology at 36% of assets, up from 31% a quarter earlier, followed by Financials and Healthcare.
- Ensign Peak Advisors's largest Q2 2026 buy was Honeywell Aerospace: 319,358 shares worth $70.6M.
- Ensign Peak Advisors added most to Advanced Micro Devices in Q2 2026, an estimated $294M increase.
- Ensign Peak Advisors's biggest Q2 2026 reduction was NVIDIA, cutting an estimated $228M.
- Ensign Peak Advisors fully exited State Street SPDR S&P 500 ETF Trust in Q2 2026, selling an estimated $144M.
- Ensign Peak Advisors's ten largest holdings make up 35% of its $60.8B portfolio in Q2 2026.
- Ensign Peak Advisors opened 53 new positions and closed 37 in Q2 2026.
- Ensign Peak Advisors's portfolio value rose 13% quarter-over-quarter to $60.8B.
Based on Ensign Peak Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.